Complete Guide to Losartan and EXP3174 Pharmacokinetics
Overview
Losartan and EXP3174 is a Angiotensin II Receptor Blocker (ARB) used in the Cardiovascular therapeutic area. It is indicated for Hypertension. Population PK simulator for losartan and its active metabolite EXP-3174, an oral ARB regimen used for hypertension. Incorporates sinusoidal gastric emptying to describe oscillatory post-dose concentration profiles.
Mechanism of Action
Losartan and EXP3174 exerts its pharmacological effect by targeting Angiotensin II type 1 receptor (AT1); active metabolite EXP-3174. As a Angiotensin II Receptor Blocker (ARB), it modulates this target to achieve therapeutic efficacy in Hypertension. Understanding the target engagement is critical for interpreting the pharmacokinetic-pharmacodynamic (PK/PD) relationship and optimizing dosing regimens.
Key Pharmacokinetic Parameters
This Population PK model for Losartan and EXP3174 characterizes the time-course of drug concentrations following Oral administration. Key parameters such as clearance (CL), volume of distribution (Vd), and absorption rate constant (Ka) define the drug's disposition. Use the interactive simulator below to explore these parameters in detail.
Dosing & Administration
Losartan and EXP3174 is administered via the Oral route. Oral administration involves absorption from the gastrointestinal tract, and bioavailability may be affected by food intake, formulation, and first-pass metabolism.
Dosing recommendations should always follow approved prescribing information. The interactive simulator allows you to explore different dosing scenarios and their impact on drug exposure metrics such as AUC, Cmax, and Ctrough.
Clinical Considerations
In the Cardiovascular therapeutic area, for the treatment of Hypertension, understanding the pharmacokinetics of Losartan and EXP3174 is essential for dose optimization and therapeutic drug monitoring. Key clinical factors that may affect Losartan and EXP3174 pharmacokinetics include:
- •Body weight and body composition
- •Renal and hepatic function
- •Drug-drug interactions and concomitant medications
- •Age, sex, and genetic polymorphisms
Interactive Losartan and EXP3174 PK Simulator
Explore Losartan and EXP3174 pharmacokinetics interactively. Adjust doses, dosing intervals, and patient covariates to visualize concentration-time profiles in real time.
Frequently Asked Questions
What is the half-life of Losartan and EXP3174?
The elimination half-life of Losartan and EXP3174 depends on patient-specific factors. Use our interactive Losartan and EXP3174 PK simulator to explore concentration-time profiles and estimate half-life under different dosing scenarios.
How is Losartan and EXP3174 administered?
Losartan and EXP3174 is administered via the Oral route. It is indicated for Hypertension. As a Angiotensin II Receptor Blocker (ARB), dosing regimens should follow approved prescribing information and clinical guidelines.
What are the key PK parameters of Losartan and EXP3174?
Key pharmacokinetic parameters for Losartan and EXP3174 include clearance (CL), volume of distribution (Vd), and elimination half-life. Our interactive simulator uses a Population PK model to characterize the pharmacokinetics of Losartan and EXP3174.
Can I simulate Losartan and EXP3174 dosing scenarios for free?
Yes! PKPDBuilder offers a completely free, interactive Losartan and EXP3174 PK simulator based on published pharmacometric models. No login required. Use it to explore different doses, dosing intervals, and patient covariates.
⚠️ Disclaimer
This guide is for research and educational purposes only. It is not intended for clinical decision-making or patient dosing. Parameters are derived from published literature and represent population estimates. Always consult approved prescribing information for clinical use.